Invitation to MSAB’s Capital Markets Day on May 7th, 2026

Capital Markets Day on May 7, 2026 in Stockholm (09:00–~13:00 CET) announced by MSAB. CEO Peter Gille and the Senior Management Team will present the company's growth strategy, market positioning and financial outlook, supported by customer cases. The event will feature presentations and live demonstrations of MSAB's mobile forensics technology and conclude with lunch.

Analysis

A public, management-led strategic narrative that showcases product demos and customer cases is a classic lever to accelerate the transition from one-off sales to recurring, higher‑visibility revenue. If management convincingly ties new software bundles or cloud-delivered modules to multi-year contracts, expect identifiable effects on valuation mechanics: a move from revenue multiple to ARR/FCF multiple could add 20–40% to enterprise value over 12–24 months for a high‑growth forensics player given low incremental CAC and high gross margins on software. The conversion path will be lumpy—procurement cycles in government and law‑enforcement customers typically materialize over 6–18 months—so near‑term churn/recognition noise is likely even if the underlying business strengthens.

Competitive dynamics favor firms that can maintain OS extraction parity and scale secure cloud ingestion; the immediate beneficiaries are vendors with robust device‑level tooling plus cloud analytics. Second‑order winners include secure enclave/TPM suppliers and cloud gov/compliance teams (who capture recurring hosting fees), while boutique forensic labs and services face margin compression as automation reduces per‑case labor hours by ~20–40% over a multi‑year horizon. A regulatory counter‑risk is real: intensified export controls or privacy litigation could close off materially sized international markets within 12–36 months, creating binary downside for players dependent on broad geographic reach.

Near term, the credible catalysts to watch are: (1) booking language moving toward multi-year ARR, (2) live demo proof points against the latest iOS/Android lock mechanisms, and (3) pipeline disclosure with contract timing. A failure on any of these risks a rapid re‑rate; conversely, explicit ARR milestones or a large multiyear public‑safety contract would validate a re‑rating thesis in 3–12 months.

Key Decisions for Investors

• Long CLBT (Cellebrite) — 6–12 month horizon. Thesis: sector re‑rating if market prizes recurring software/analytics revenue; target 30–50% upside. Risk: technology parity or loss of large public contracts; stop‑loss at 20% below entry or hedge with short puts.
• Buy 9–15 month call spread on CLBT (debit spread to limit premium) — reduces cash outlay while capturing move if market re‑prices forensics vendors post‑strategy disclosures; aim for 2.5x–4x return if catalyst validates ARR transition.
• Overweight MSFT (Azure Gov) or AMZN (AWS Gov) — 12 month horizon. Thesis: increased secure cloud ingestion for forensic data gives incremental, sticky revenue; look for 5–10% relative outperformance vs peers. Risk: macro softness; size as modest sector tilt (1–2% portfolio).
• Event hedge: buy short‑dated volatility on the primary forensics names into the next major product/strategy reveal (or buy protective puts post‑reveal) — this protects against a binary negative demo or regulatory scare that can compress multiples quickly.